Results for “”

Entry Author Date Location
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More 04/19/19 National
It’s Tough to Find Drugs to Bind to RNA: Arrakis Nabs $75M to Help 04/18/19 Boston
$100M for Talaris Gives Surgeon a Shot to Reinvent Organ Transplants 04/18/19 Boston
Hatteras Launches New Fund With $94M for Life Science Investments 04/15/19 Raleigh Durham
How an Ohio Kids’ Hospital Quietly Became Ground Zero for Gene Therapy 04/15/19 National
Lyft, Uber, and the Changing Disclosure Rules For Unicorn IPOs 04/12/19 San Francisco
Thwarting Opposition, Bristol Gets Shareholder OK for $74B Celgene Buyout 04/12/19 New York
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More 04/12/19 National
AskBio Reels In $235M to Advance Gene Therapy Clinical Trials 04/11/19 Raleigh Durham
Senators Grill Pharmacy Benefit Execs About Skyrocketing Drug Prices 04/09/19 National
VC Trends in 2019: More Money, Fewer Deals But Women Still Get Less 04/09/19 National
Bio Roundup: Gottlieb’s Goodbye, AACR Recap, Migraine Drug Fight & More 04/05/19 National
Skills, Pills, & Hospital Bills: Amazon Debuts Alexa Health Features 04/04/19 Seattle
AACR 2019 Roundup: Notes from a Weekend of Early Stage Cancer Results 04/03/19 National
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More 03/29/19 National
Lyft Raises $2.2B in IPO, Pegging Valuation at Over $24B 03/28/19 San Francisco
Precision Bio’s IPO Raises $126M for Pipeline of Gene-Edited Drugs 03/27/19 Raleigh Durham
FTC Queries Internet Providers on Consumer Data Collection and Use 03/27/19 San Francisco
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More 03/22/19 National
Urovant Bladder Drug Hits Test Goals But Can’t Outpace Generic Rival 03/19/19 San Diego
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
Blood Test Study Meets Goal, Validates Epic’s Prostate Cancer Target 03/13/19 San Diego
FDA Clears Aerie’s Combo Glaucoma Drug, But Will it Sell? 03/13/19 New York
Drug-Price Watchdog ICER Dives into Trump-Fueled Pharma Rebate Debate 03/13/19 National
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski 03/11/19 National
Bio Roundup: Gottlieb Exits, Bristol Defends, Biogen Buys & More 03/08/19 National
Steering Lyft’s IPO: What Investors Will Weigh During the Roadshow 03/07/19 San Francisco
Blue Squad Aims to Bring Election Tech Up and Down the Ballot 03/06/19 National
Two Years and Done: FDA Commissioner Gottlieb To Resign 03/05/19 National
Precision Bio Preps IPO to Test “Off-the-Shelf” Cancer Cell Therapy 03/04/19 Raleigh Durham
Page 1 of 42 next page »